NFKB1 and hematologic disorder: NF-κB subunits are often activated in solid or hematological malignancies as the result of rearrangements/mutations in their genes or in genes encoding components of the NF-κB signaling pathway, persistent autocrine or paracrine stimulation through specific cell surface receptors, or viral or cellular oncoprotein activity (for review see [2], [3]).